Clinical Trials Directory

Trials / Completed

CompletedNCT04670003

Spread Analysis of COVID-19 Outbreak in France by Self-assessment Web-application

Spread Analysis of COVID-19 Outbreak in France by Self-assessment Web-application: an Observational Study

Status
Completed
Phase
Study type
Observational
Enrollment
4,975 (actual)
Sponsor
Weprom · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A coronavirus pandemic began on 12/31/2019 with a first Chinese patient. As of 04/04/2020, the epidemic affects more than 190 countries with more than 50 million official contaminations and 1,251,000 deaths. (Univ J Hopkins). This virus causes a pathology ranging from simple flu-like symptoms in 80% of cases to acute respiratory distress syndromes requiring intensive care in 5% of cases and a death rate of 1.4 to 4% of cases. Viral contamination is airborne and fecal A first epidemic wave crossed France in March / April 2020 then a second in October / November with a source of contamination which began in mid-August 2020. The sources of propagation are not well known (what places, what times, what contacts…? ) In the context of the health crisis linked to the coronavirus, knowledge of the sources of propagation of this 2nd wave is an important issue to guide end of lockdown and second lockdown policies.

Conditions

Interventions

TypeNameDescription
OTHERusersData of users of the web-application

Timeline

Start date
2021-01-02
Primary completion
2021-03-30
Completion
2021-03-30
First posted
2020-12-17
Last updated
2021-04-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04670003. Inclusion in this directory is not an endorsement.